Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -0.46% | 129.12 | 0.0% | $2948.82m | |
| BNGO | BioNano Genomics, Inc. | 7.63% | 7.48 | 0.0% | $1266.47m | |
| GILD | Gilead Sciences, Inc. | -0.51% | 62.08 | 1.0% | $648.03m | |
| AMGN | Amgen, Inc. | -0.89% | 239.50 | 1.3% | $580.49m | |
| CRSP | CRISPR Therapeutics AG | 4.79% | 220.10 | 0.6% | $565.73m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.00% | 156.65 | 2.0% | $542.66m | |
| NVAX | Novavax, Inc. | 0.40% | 130.50 | 92.9% | $497.23m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.16% | 517.10 | 2.7% | $480.64m | |
| BIIB | Biogen, Inc. | -0.64% | 278.50 | 1.7% | $361.59m | |
| ILMN | Illumina, Inc. | -0.28% | 370.00 | 3.5% | $357.57m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.39% | 227.00 | 1.9% | $345.77m | |
| BNTX | BioNTech SE | -2.22% | 103.50 | 0.0% | $330.67m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.26% | 90.13 | 13.8% | $284.33m | |
| OCGN | Ocugen, Inc. | 3.21% | 2.25 | 0.0% | $278.79m | |
| EXAS | EXACT Sciences Corp. | -0.05% | 147.22 | 19.6% | $253.05m |
Company Profile
Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.